Ken Stern & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$687K Hold
2,816
0.3% 46
2018
Q2
$583K Buy
2,816
+22
+0.8% +$4.67K 0.27% 47
2018
Q1
$577K Sell
2,794
-20
-0.7% -$4.2K 0.25% 45
2017
Q4
$534K Sell
2,814
-26
-0.9% -$4.98K 0.23% 52
2017
Q3
$540K Sell
2,840
-53
-2% -$9.6K 0.24% 48
2017
Q2
$500K Hold
2,893
0.23% 56
2017
Q1
$478K Sell
2,893
-21
-0.7% -$3.21K 0.22% 53
2016
Q4
$411K Sell
2,914
-23
-0.8% -$3.39K 0.21% 68
2016
Q3
$467K Hold
2,937
0.32% 45
2016
Q2
$434K Buy
2,937
+65
+2% +$9.59K 0.34% 49
2016
Q1
$407K Buy
2,872
+463
+19% +$62K 0.28% 50
2015
Q4
$342K Buy
2,409
+106
+5% +$14.1K 0.23% 62
2015
Q3
$282K Buy
+2,303
New +$300K 0.22% 57

Other funds holding TMO

Ken Stern & Associates's TMO Position: Q3 2018 in Review

Ken Stern & Associates held its Thermo Fisher Scientific (TMO) position steady in Q3 2018 at 2,816 shares worth $687K. The position accounts for 0.3% of the portfolio, ranked #46.

Ken Stern & Associates first reported a position in TMO in Q3 2015 and has held it in 13 quarters since. 1,350 funds tracked by Wall St. Rank hold TMO as of Q3 2018.

  • Ken Stern & Associates held 2,816 shares of Thermo Fisher Scientific worth $687K as of Q3 2018.
  • Ken Stern & Associates left its Thermo Fisher Scientific share count unchanged in Q3 2018.
  • Thermo Fisher Scientific made up 0.3% of Ken Stern & Associates's portfolio in Q3 2018, its #46 holding.
  • Ken Stern & Associates first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 13 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.